NDC codes

415010 NDC codes with hospital pricing data in the network.

• NDC 43598-0698-58 — Carboprost tromethamine injection 250 mcg/mLAI (475 hospitals, 38,793–39,837 samples)
• NDC 67457-0440-22 — Ondansetron injection, 4 mg per 2 mLAI (198 hospitals, 38,478–39,801 samples)
• NDC 62332-0518-05 — Tobramycin 0.3% eye dropsAI (405 hospitals, 38,555–39,761 samples)
• NDC 00121-1154-40 — Lactulose oral solution, 10 g per 15 mLAI (427 hospitals, 38,562–39,759 samples)
• NDC 61314-0203-15 — Pilocarpine 1% eye dropsAI (947 hospitals, 38,604–39,747 samples)
• NDC 51672-1298-01 — ketoconazole 2 % topical creamAI (540 hospitals, 38,573–39,734 samples)
• NDC 68308-0152-15 — Nystatin 100,000 unit per gram topical powderAI (468 hospitals, 38,571–39,714 samples)
• NDC 45802-0580-84 — Scopolamine 1 mg transdermal patch (3-day)AI (316 hospitals, 38,098–39,709 samples)
• NDC 00168-0163-15 — Clobetasol propionate 0.05% topical creamAI (251 hospitals, 38,648–39,701 samples)
• NDC 60505-0582-04 — Moxifloxacin eye dropsAI (611 hospitals, 38,635–39,679 samples)
• NDC 00409-6637-14 — Intravenous sodium bicarbonate 8.4% solutionAI (388 hospitals, 37,837–39,673 samples)
• NDC 67457-0297-50 — Ethacrynate sodium 50 mg IV injectionAI (207 hospitals, 38,829–39,666 samples)
• NDC 69339-0138-17 — CHLORHEXIDINE GLUCONATE 0.12 % MOUTHWASHAI (280 hospitals, 38,566–39,664 samples)
• NDC 62332-0600-25 — Ketorolac injection, 30 mg/mLAI (251 hospitals, 37,783–39,637 samples)
• NDC 00378-9119-98 — Fentanyl 72-hour skin patch, 12 mcg per hourAI (643 hospitals, 38,563–39,562 samples)
• NDC 43598-0548-50 — PROPOFOL 10 MG/ML INTRAVENOUS EMULSIONAI (132 hospitals, 37,454–39,551 samples)
• NDC 00781-3156-95 — Intravenous acetaminophen 1000 mg solutionAI (408 hospitals, 38,929–39,532 samples)
• NDC 00378-0871-99 — Clonidine 0.1 mg weekly patchAI (523 hospitals, 38,454–39,507 samples)
• NDC 66689-0038-50 — Lactulose oral liquid, 30 mLAI (185 hospitals, 38,251–39,466 samples)
• NDC 51672-1267-05 — Triamcinolone 0.1% paste, 5 g tubeAI (634 hospitals, 38,196–39,393 samples)
• NDC 00019-1332-06 — Optiray 300 contrast injectionAI (43 hospitals, 39,231–39,375 samples)
• NDC 50383-0779-31 — Lactulose 10 g/15 mL oral solutionAI (193 hospitals, 38,229–39,345 samples)
• NDC 00409-6010-25 — Propofol intravenous emulsion, 200 mg per 20 mLAI (287 hospitals, 37,707–39,345 samples)
• NDC 70860-0776-41 — Ondansetron injection, 4 mg per 2 mLAI (225 hospitals, 36,135–39,321 samples)
• NDC 00338-1301-48 — Cefepime 2 g premixed bagAI (189 hospitals, 39,095–39,311 samples)
• NDC 00121-0873-16 — Lactulose oral solution 10 g per 15 mLAI (505 hospitals, 37,969–39,256 samples)
• NDC 43598-0919-11 — Carboprost tromethamine injection, 250 mcg per mLAI (98 hospitals, 38,439–39,249 samples)
• NDC 00009-0047-25 — Methylprednisolone sodium succinate injection 125 mgAI (711 hospitals, 19,362–39,234 samples)
• NDC 52565-0009-50 — Lidocaine 4% topical solution, 50 mLAI (352 hospitals, 38,099–39,179 samples)
• NDC 62332-0599-01 — Ketorolac 15 mg/mL injectionAI (146 hospitals, 35,647–39,139 samples)
• NDC 72611-0725-01 — Ketorolac 60 mg injection for muscle useAI (189 hospitals, 36,560–39,134 samples)
• NDC 00407-1414-98 — Iohexol 350 contrast dye for IV injectionAI (112 hospitals, 38,307–39,126 samples)
• NDC 51672-3020-09 — Lidocaine 5% external ointmentAI (432 hospitals, 37,999–39,124 samples)
• NDC 00472-0337-30 — HYDROCORTISONE 2.5 % TOPICAL CREAMAI (164 hospitals, 37,997–39,104 samples)
• NDC 63323-0106-02 — Magnesium sulfate IV solution 2 g in 50 mLAI (624 hospitals, 36,286–39,103 samples)
• NDC 17478-0226-12 — PILOCARPINE 4 % EYE DROPSAI (98 hospitals, 38,212–39,103 samples)
• NDC 33342-0329-15 — TRIAMCINOLONE ACETONIDE 0.1 % TOPICAL CREAMAI (154 hospitals, 38,022–39,093 samples)
• NDC 00121-0903-40 — Lidocaine 2% mucosal solutionAI (268 hospitals, 37,977–39,093 samples)
• NDC 21922-0009-09 — DICLOFENAC 1 % TOPICAL GELAI (198 hospitals, 37,975–39,073 samples)
• NDC 45802-0160-00 — Diclofenac sodium 1% topical gelAI (191 hospitals, 37,975–39,073 samples)
• NDC 63323-0806-05 — Fentanyl citrate injection, preservative-free, 250 mcg per 5 mLAI (371 hospitals, 33,056–39,059 samples)
• NDC 00270-7015-46 — Vueway IV contrast solution for imagingAI (130 hospitals, 38,978–39,059 samples)
• NDC 42291-0076-15 — CLOBETASOL 0.05 % TOPICAL CREAMAI (202 hospitals, 37,972–39,043 samples)
• NDC 43598-0326-75 — Ciprofloxacin and dexamethasone eye dropsAI (722 hospitals, 37,880–39,041 samples)
• NDC 69315-0308-05 — Ciprofloxacin 0.3% eye dropsAI (509 hospitals, 37,876–39,037 samples)
• NDC 00378-9121-98 — Fentanyl 25 mcg/hr skin patchAI (542 hospitals, 37,847–39,017 samples)
• NDC 14789-0122-05 — Fluorescein 10% intravenous solutionAI (255 hospitals, 38,110–39,010 samples)
• NDC 65219-0383-08 — Low-osmolar iodinated contrast dye, per mLAI (22 hospitals, 38,973 samples)
• NDC 00019-1333-95 — Ioversol 350 contrast injection syringeAI (56 hospitals, 38,973 samples)
• NDC 00019-1332-90 — Low-osmolar iodinated contrast dye, per milliliterAI (17 hospitals, 38,973 samples)